Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

ClinicalTrials.gov ID: NCT00084266

Public ClinicalTrials.gov record NCT00084266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Linezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus

Study identification

NCT ID
NCT00084266
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
1,225 participants

Conditions and interventions

Interventions

  • linezolid (Zyvox) Drug
  • vancomycin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Jan 31, 2012

2004 – 2010

United States locations

U.S. sites
108
U.S. states
32
U.S. cities
74
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35233
Pfizer Investigational Site Birmingham Alabama 35249
Pfizer Investigational Site Birmingham Alabama 35294
Pfizer Investigational Site Huntsville Alabama 35801
Pfizer Investigational Site Montgomery Alabama 36106
Pfizer Investigational Site Montgomery Alabama 36111
Pfizer Investigational Site Phoenix Arizona 85013
Pfizer Investigational Site Los Angeles California 90033
Pfizer Investigational Site Orange California 92868
Pfizer Investigational Site Redlands California 92373
Pfizer Investigational Site Sacramento California 95817
Pfizer Investigational Site San Diego California 92120
Pfizer Investigational Site San Diego California 92123
Pfizer Investigational Site San Francisco California 94110
Pfizer Investigational Site Denver Colorado 80204
Pfizer Investigational Site Denver Colorado 80205
Pfizer Investigational Site Denver Colorado 80218
Pfizer Investigational Site Newark Delaware 19718
Pfizer Investigational Site Washington D.C. District of Columbia 20017
Pfizer Investigational Site Washington D.C. District of Columbia 20037
Pfizer Investigational Site Brandon Florida 33511
Pfizer Investigational Site Fort Lauderdale Florida 33316
Pfizer Investigational Site Gainesville Florida 32610
Pfizer Investigational Site Jacksonville Florida 32209
Pfizer Investigational Site Jackson Florida 32209
Pfizer Investigational Site Miami Florida 33136
Pfizer Investigational Site Orlando Florida 32801
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Tampa Florida 33607
Pfizer Investigational Site Augusta Georgia 30909
Pfizer Investigational Site Augusta Georgia 30912
Pfizer Investigational Site Decatur Georgia 30030
Pfizer Investigational Site Decatur Georgia 30033
Pfizer Investigational Site Honolulu Hawaii 96817
Pfizer Investigational Site Chicago Illinois 60612
Pfizer Investigational Site North Chicago Illinois 60064
Pfizer Investigational Site Oak Park Illinois 60302-2566
Pfizer Investigational Site Springfield Illinois 62701
Pfizer Investigational Site Springfield Illinois 62702
Pfizer Investigational Site Springfield Illinois 62703
Pfizer Investigational Site New Albany Indiana 47151
Pfizer Investigational Site Hazard Kentucky 41701
Pfizer Investigational Site Lexington Kentucky 40536
Pfizer Investigational Site Louisville Kentucky 40202
Pfizer Investigational Site Louisville Kentucky 40206
Pfizer Investigational Site Baltimore Maryland 21201
Pfizer Investigational Site Boston Massachusetts 02111
Pfizer Investigational Site Boston Massachusetts 02114
Pfizer Investigational Site Boston Massachusetts 02115
Pfizer Investigational Site Boston Massachusetts 02118
Pfizer Investigational Site Springfield Massachusetts 01199
Pfizer Investigational Site Ann Arbor Michigan 48109-0331
Pfizer Investigational Site Detroit Michigan 48201
Pfizer Investigational Site Detroit Michigan 48202
Pfizer Investigational Site Detroit Michigan 48210
Pfizer Investigational Site Saint Loius Missouri 63110
Pfizer Investigational Site St Louis Missouri 63110-1010
Pfizer Investigational Site St Louis Missouri 63110
Pfizer Investigational Site Omaha Nebraska 68131
Pfizer Investigational Site Las Vegas Nevada 89109
Pfizer Investigational Site Reno Nevada 89502
Pfizer Investigational Site Reno Nevada 89503
Pfizer Investigational Site Hackensack New Jersey 07601
Pfizer Investigational Site Albany New York 12208
Pfizer Investigational Site Brooklyn New York 11215
Pfizer Investigational Site Buffalo New York 14215
Pfizer Investigational Site New York New York 10011
Pfizer Investigational Site New York New York 10021-9800
Pfizer Investigational Site New York New York 10029
Pfizer Investigational Site Rochester New York 14642-8410
Pfizer Investigational Site Rochester New York 14642
Pfizer Investigational Site The Bronx New York 10457
Pfizer Investigational Site Greensboro North Carolina 27401
Pfizer Investigational Site Fargo North Dakota 58112
Pfizer Investigational Site Fargo North Dakota 58122
Pfizer Investigational Site Cincinnati Ohio 45219
Pfizer Investigational Site Cincinnati Ohio 45267-0558
Pfizer Investigational Site Columbus Ohio 43210
Pfizer Investigational Site Columbus Ohio 43214
Pfizer Investigational Site Columbus Ohio 43215
Pfizer Investigational Site Columbus Ohio 43222
Pfizer Investigational Site Sylvania Ohio 43560
Pfizer Investigational Site Toledo Ohio 43608
Pfizer Investigational Site Toledo Ohio 43614
Pfizer Investigational Site Portland Oregon 97213
Pfizer Investigational Site Portland Oregon 97220
Pfizer Investigational Site Abington Pennsylvania 19001
Pfizer Investigational Site Allentown Pennsylvania 18103
Pfizer Investigational Site Bethlehem Pennsylvania 18017
Pfizer Investigational Site Philadelphia Pennsylvania 19102
Pfizer Investigational Site Pittsburgh Pennsylvania 15213
Pfizer Investigational Site Providence Rhode Island 02903
Pfizer Investigational Site Charleston South Carolina 29425
Pfizer Investigational Site Sioux Falls South Dakota 57104
Pfizer Investigational Site Sioux Falls South Dakota 57105
Pfizer Investigational Site Sioux Falls South Dakota 57117-5045
Pfizer Investigational Site Nashville Tennessee 37232-7110
Pfizer Investigational Site Nashville Tennessee 37232
Pfizer Investigational Site Houston Texas 77030-1608
Pfizer Investigational Site Irving Texas 75061
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site San Antonio Texas 78284
Pfizer Investigational Site San Marcos Texas 78666
Pfizer Investigational Site Sequin Texas 78155
Pfizer Investigational Site Temple Texas 76508
Pfizer Investigational Site Murray Utah 84157
Pfizer Investigational Site Richmond Virginia 23219
Pfizer Investigational Site Winchester Virginia 22601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00084266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2012 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00084266 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →